Overview
AI foundation model integrating genomic, transcriptomic, immune, and clinical signals for tumor portraits, biomarker discovery, trial optimization, and precision therapy decisions across oncology and immune-mediated diseases.
Product and company
BostonGene — Biotechnology is a verified product offering linked to the Brel Digital company profile for BostonGene.
Use cases
AI foundation model integrating genomic, transcriptomic, immune, and clinical signals for tumor portraits, biomarker discovery, trial optimization, and precision therapy decisions across oncology and immune-mediated diseases.
Target customer
Pharmaceutical R&D teams, biotech sponsors, and academic cancer centers seeking multimodal AI for patient selection, trial design, and companion biomarker strategies.
Technologies
Primary technologies assigned from the linked company profile: AI Governance, Deep Learning, Healthcare Analytics, Large Language Models, Machine Learning, Predictive Analytics.
Sources and references
- Official product / company source: https://bostongene.com/news-and-publications/news/bostongene-receives-frost-and-sullivan-s-2026-global-company-of-the-year-for-advancing-in-ai-driven-multimodal-oncology-platforms
- Supporting source: https://bostongene.com/news-and-publications/news/bostongene-ceo-andrew-feinberg-to-deliver-keynote-at-mobile-world-congress-barcelona-2026
Product facts are limited to information already verified on the linked Brel company profile and its cited official URLs. No speculative capabilities are added.
Last reviewed
This product profile was last reviewed on 2026-07-14.
Correction request
If this product record is inaccurate or outdated, submit a correction through Brel Digital’s Corrections Policy.
Features and capabilities
- AI foundation model integrating genomic, transcriptomic, immune, and clinical signals for tumor portraits, biomarker discovery, trial optimization, and precision therapy decisions across oncology and immune-mediated diseases.
Extracted from the linked company product description already verified on Brel. No capabilities were invented.